Skip to content

LifeMD, Inc. LFMD Preferred Stock, Shares Authorized

Preferred Stock, Shares Authorized at other companies

CVS Health logo
CVS HealthCVS
Spok Holdings logo
Spok HoldingsSPOK
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
Cardinal Health logo
Cardinal HealthCAH

Other financials

Income statement

See full
Revenue$50.2M-1.4%
Gross profit$44.2M+3.5%
Operating income-$8.9M-656%
Net income-$8.9M-4,728%
EPS (diluted)-$0.20-900%

Balance sheet

See full
Cash & equivalents$34.5M+7.9%
Total debt$6.2M-76.9%
Total equity$15.0M+746%
Total assets$70.1M-4.7%

Cash flow

See full
Operating cash flow$444.6K-85.5%
CapEx$105.2K-10.5%
Free cash flow$339.4K-88.5%

Valuation

See full
Market cap$235.53M-61.7%
Enterprise value$207.22M-66.2%
P/E41.6×
P/S1.3×-2.3×

Profitability

See full
Gross margin86.1%+0.9pp
Operating margin-9.8%-0.9pp
Net margin3.1%+1.8pp
FCF margin10.4%+1.7pp

Returns & leverage

See full
Return on equity-393.6%
Debt / equity0.4×
Current ratio+0.2×

Where this comes from

Reported directly by LifeMD, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.

The official record: LifeMD, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about LifeMD, Inc.'s preferred stock, shares authorized.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LifeMD, Inc.'s preferred stock, shares authorized?
LifeMD, Inc. (LFMD) reported preferred stock, shares authorized of $5M in Q1 2026.
How has LifeMD, Inc.'s preferred stock, shares authorized changed year-over-year?
LifeMD, Inc.'s preferred stock, shares authorized decreased by 0.0% year-over-year, from $5M to $5M.
What is the long-term trend for LifeMD, Inc.'s preferred stock, shares authorized?
Over 5 years (2020 to 2025), LifeMD, Inc.'s preferred stock, shares authorized has grown at a 0.0% compound annual growth rate (CAGR), from $5M to $5M.